Stock Events

Stock Events

Titan Pharmaceuticals 

$1.21
47
-$0.03-2.06% Tuesday 19:33

Statistics

Day High
1.25
Day Low
1.21
52W High
5.3
52W Low
1.21
Volume
77,238
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Feb 12
$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

17NovExpected
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.65
-0.32
0.02
0.35
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-4.71MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TTNP. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alkermes
ALKS
Mkt Cap5.69B
Alkermes plc develops extended-release injectable and oral products for the treatment of prevalent and chronic diseases, similar to Titan's focus on therapeutic areas.
Indivior Pharmaceuticals
INDV
Mkt Cap4.56B
Indivior PLC offers products for the treatment of opioid dependence, directly competing with Titan's Probuphine.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.7B
Teva Pharmaceutical Industries Limited manufactures generic and specialty medicines, including treatments in areas that Titan Pharmaceuticals targets.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its Janssen Pharmaceuticals, Inc. subsidiary, competes in the pharmaceuticals sector, including areas of interest to Titan.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. provides healthcare solutions that include pharmaceutical products in therapeutic areas that overlap with Titan's interests.
Pfizer
PFE
Mkt Cap149.77B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products, including those for treatments in areas Titan Pharmaceuticals is focused on.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie Inc. researches and develops pharmaceutical products, competing in therapeutic areas similar to those targeted by Titan Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb Company discovers, develops, and delivers innovative medicines that address serious diseases, in competition with Titan's product range.
Novartis
NVS
Mkt Cap279.67B
Novartis AG focuses on patented medicines for a range of diseases, some of which are also targeted by Titan Pharmaceuticals.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline plc engages in the creation and discovery of pharmaceutical products, including in areas that compete with Titan Pharmaceuticals' interests.

About

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.
Show more...
CEO
Mr. Weei Jye Chay
Employees
4
Country
United States
ISIN
US8883146065

Listings

0 Comments

Share your thoughts

FAQ

What is Titan Pharmaceuticals stock price today?▼
The current price of TTNP is $1.21 USD — it has decreased by -2.06% in the past 24 hours. Watch Titan Pharmaceuticals stock price performance more closely on the chart.
What is Titan Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Titan Pharmaceuticals stocks are traded under the ticker TTNP.
Is Titan Pharmaceuticals stock price growing?▼
TTNP stock has fallen by -3.61% compared to the previous week, the month change is a -73.66% fall, over the last year Titan Pharmaceuticals has showed a -68.29% decrease.
What is Titan Pharmaceuticals revenue for the last year?▼
Titan Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Titan Pharmaceuticals net income for the last year?▼
TTNP net income for the last year is -4.71M USD.
Does Titan Pharmaceuticals pay dividends?▼
Yes, TTNP dividends are paid en. The last dividend per share was 0.01 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Titan Pharmaceuticals have?▼
As of May 06, 2026, the company has 4 employees.
In which sector is Titan Pharmaceuticals located?▼
Titan Pharmaceuticals operates in the Health & Wellness sector.
When did Titan Pharmaceuticals complete a stock split?▼
The last stock split for Titan Pharmaceuticals was on January 09, 2024 with a ratio of 1:20.
Where is Titan Pharmaceuticals headquartered?▼
Titan Pharmaceuticals is headquartered in New York, United States.